CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below. Call to Order Roll Call Discussion of ICOC Chair, ICOC Vice-chair, and ...

1) Successfully developed ART352-L, a liposomal formulation of recombinant human WNT3A protein, that is applied ex vivo, to harvested autologous bone graft (autograft) to enhance the osteogenic ...

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

3. Teacher designs questions to test understanding of lecture topics and concepts of disease causes, symptoms, and treatments ...

have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...

There is no shortage of myths and misconceptions when it comes to stem cell research and regenerative medicine. Here we address the most common concerns. If you have more questions that aren’t ...

For more information on our clinical trials, visit our CIRM-Funded Clinical Trials page.

Parkinson’s disease is a neurodegenerative disease that affects approximately a million people in the United States and seven million people around the world. Symptoms include tremors, slow movement, ...

Retinal degeneration represents a group of blinding diseases that are increasingly impacting the health and well being of Californians. It is estimated that by 2020, over 450,000 Californians will ...

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

David Higgins, PhD, earned his PhD in molecular biology and genetics from the University of Rochester in New York, followed by a postdoctoral fellowship at the National Cancer Institute before moving ...